Navigation Links
Mouse Model Beneficial to Study of Head and Neck Cancer

The development of a mouse model by the Oregon Health & Science University Cancer Institute research laboratory has proved beneficial in the study of the often devastating// head and neck squamous cell cancers.

The research was conducted by Xiao-Jing Wang, M.D., Ph.D., and his colleagues. The results of their research breakthrough have been published in the May 15 issue of Genes & Development.

‘This is the first animal model that mimics human head and neck cancer at both the pathological and the molecular levels with 100 percent incidence,’ Wang said.

While scientists have identified some genes involved in head and neck squamous (HNSCC)cell carcinoma , overall, progress has been hampered by the lack of an animal model to study the development and progression of the disease. ‘This model will provide a valuable tool to screen for novel therapeutic and preventive approaches for this often deadly cancer,’ said Wang, head of the Division of Molecular Biology of Head and Neck Cancer in the OHSU School of Medicine and a member of the OHSU Cancer Institute.

Head and neck squamous cell carcinoma is the sixth most common cancer in the United States. It has a low survival rate - fewer than 50 percent of head and neck patients survive beyond five years, and this rate has not changed in the past 20 years, despite progress in developing therapies for other cancers. Patients are usually resistant to routine chemotherapy and radiation therapy. In addition, the quality of life for survivors is usually miserable because the location of the cancer often destroys structures critical to speaking, breathing and swallowing.

In their research, Wang and her colleagues engineered a strain of mice to specifically lack expression of the transforming growth factor beta receptor II (TGFbRII) in epithelial cells of the oral cavity. By then introducing activating mutations in either the H-ras or K-ras (two different isoforms of the Ras GTPase), t
'"/>




Page: 1 2

Related medicine news :

1. Mouse Allergen Found In Homes Could Trigger Asthma In Kids
2. Researchers Develop Mouse Model Of Brain Tumor
3. German Scientists Create Stem Cells From Mouse Testes
4. Mouse Models To Determine The Cause Of Aggressive Leukemia
5. Scientists Discover New RNAs in Mouse Testicles
6. Scientists Isolate Leukemia Stem Cells in Mouse Model
7. Mouse Model Demonstrates Immune System Reaction In Chlamydia Infection
8. Mouse Gene With Gene Stutter Will Help Leukemia Research
9. Rett Syndrome Reversed in Genetic Mouse Model
10. Treatment Extends Survival in Mouse Model of Spinal Muscular Atrophy
11. Mouse Study Suggests Anxiety Disorders Take Root in Infancy
Post Your Comments:
(Date:7/8/2008)...following statement was issued,today by the law fi...otice is hereby given that a class action lawsuit ...the Middle District of Tennessee on behalf,of all ...q: HWAY ),("Healthways" or the "Company") from Oc...e (the "Class Period")., If you wish to discuss t...
(Date:7/8/2008)...elays in Oxygen Orders, Lack of,Trained Technician... -- The new Medicare,competitive bidding program f...nd chaos for beneficiaries, physicians, hospital d...viders across the country since it,was implemented... program has triggered widespread disruptions in s...
(Date:7/8/2008)...ociety of Hematology (ASH) is proud to announce th... Pathway Grant. The grant is given to training pro...plementation of novel hematology-related training ...sity, Donald Mahoney Jr., MD, of Baylor College of...Sinai School of Medicine, will each receive the gr...
(Date:7/8/2008)...os Innovation,s Proprietary,Device-Free Remote Mo... and Medical Costs, N...ovations, a pioneer,in assisting clients to achiev...ce improvement through a device-free remote monito...e Iowa Medicaid Congestive Heart Failure,Populatio...
Breaking Medicine News(10 mins):Health News:Shareholder Class Action Filed Against Healthways Inc. By The Law Firm of Schiffrin Barroway Topaz & Kessler, LLP 2Health News:Shareholder Class Action Filed Against Healthways Inc. By The Law Firm of Schiffrin Barroway Topaz & Kessler, LLP 3Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 2Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 3Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 4Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 5Health News:Iowa Medicaid Demonstration Finds Tel-Assurance(R) Remote Monitoring Platform Improved Health Status and Saved $5 Million 2Health News:Iowa Medicaid Demonstration Finds Tel-Assurance(R) Remote Monitoring Platform Improved Health Status and Saved $5 Million 3
...test developed by a team led by a University of Le...rnment’s Independent Depleted Uranium// Oversight ...uranium (DU) during the 1991 Gulf Conflict. Ra...ology, developed the test with Postdoctoral Fellow...
...udying the genetic make-up using blood samples to ...g treatment, has been in practice//. Now, scientis...thods based on such existing tests that might reve...come victims of substance abuse or suffer antisoci...
...University of Iowa study has revealed that it may ...ions like panic disorder with blood tests//. This ...information in immature white blood cells. "The ...quantum leap in psychiatry," said the study's lead...
...searchers in the United States have developed a me...ll four types of the dengue// virus. The dengue v...cephalitis. The four types of virus are all suffic...iduals vaccinated against one virus type are still...
Other Medicine News:Health News:DU Test Finds UK Troops Uranium Free 2Health News:Genetic Tests to Reveal ‘substance Abuse’ Tendenci 2Health News:Genetic Tests to Reveal ‘substance Abuse’ Tendenci 3Health News:Mental Health Conditions Could Be Detected With Blood Tests 2
(Date:7/7/2008)...des ANA598 and ANA773 Acting via Independ... Conference Call Today at 2:00 PM PDT, ...s Pharmaceuticals,Inc. (Nasdaq: ANDS ) announced...of the Toll-Like Receptor-7 (TLR7) mechanism for t...linical pharmacology testing,and the results of co...
(Date:7/7/2008).../ -- GeoVax Labs, Inc. (OTC,Bulletin Board: GOVX),...al,company specializing in the prevention and trea...erational update on the company,s progress,towards...l testing and,plans to proceed into therapeutic hu...human trials evaluating GeoVax AIDS vaccines have ...
(Date:7/7/2008)...Top Performer in the Body, SEATTLE, July 7 /PRNew... comes to their antioxidant powers in the body: ki...mpared to other antioxidant-rich fruits and,berrie...ournal of the,American College of Nutrition., Ant...ed flavonoids that,may have the power to neutraliz...
(Date:7/3/2008)...Newswire/ -- All newborn infants,should be screene...irth,according to a new recommendation from the U...tion and the accompanying summary of evidence appe...hose hearing is impaired at birth, during infancy ...l and nonverbal communication and,social skills, i...
Breaking Medicine Technology:Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 2Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 3Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 4Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 5GeoVax Reports Progress on Its AIDS Vaccine Technology 2GeoVax Reports Progress on Its AIDS Vaccine Technology 3GeoVax Reports Progress on Its AIDS Vaccine Technology 4GeoVax Reports Progress on Its AIDS Vaccine Technology 5Kiwifruit: Antioxidant Power in Quantity and Quality 2Task Force Recommends Screening for Hearing Loss in All Newborns 2Task Force Recommends Screening for Hearing Loss in All Newborns 3Lexicon Files Investigational New Drug Application for LX1032 as a Potential Treatment for Carcinoid Syndrome 2358 1Lexicon Files Investigational New Drug Application for LX1032 as a Potential Treatment for Carcinoid Syndrome 2358 2Lexicon Files Investigational New Drug Application for LX1032 as a Potential Treatment for Carcinoid Syndrome 2358 3LeMaitre Vascular Acquires Biomateriali a Vascular Graft Manufacturer 2355 1LeMaitre Vascular Acquires Biomateriali a Vascular Graft Manufacturer 2355 2LeMaitre Vascular Acquires Biomateriali a Vascular Graft Manufacturer 2355 3Manor Care To Vigorously Contest TRO 8681 1Manor Care To Vigorously Contest TRO 8681 2Kaiser Permanente Group Health Study Shows Depression Worsens HIV Treatment 1110 1Kaiser Permanente Group Health Study Shows Depression Worsens HIV Treatment 1110 2Kaiser Permanente Group Health Study Shows Depression Worsens HIV Treatment 1110 3
...monstrate Significant Survival Benefit in,Liver Ca...ll/ -- Bayer,HealthCare Pharmaceuticals Inc. and O...avar(R) (sorafenib) tablets significantly,extended...carcinoma,(HCC), or primary liver cancer versus th...). Results were presented at the 43rd,annual meeti...
...NESS WIRE)--Jun 4, 2007 - GenVec, Inc.,(Nasdaq: GN...y and,efficacy data from the clinical development ...nted in a poster session on,gastrointestinal cance...linical Oncology in Chicago, IL by Dr. Mitchell Po...sion of the posters then,concluded the Saturday mo...
Other Medicine Technology:Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 2Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 3Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 4Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 5Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 6Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 7GenVec Announces Update of Safety and Efficacy Data from Pivotal,Phase II/III PACT Study of TNFerade at ASCO 2GenVec Announces Update of Safety and Efficacy Data from Pivotal,Phase II/III PACT Study of TNFerade at ASCO 3GenVec Announces Update of Safety and Efficacy Data from Pivotal,Phase II/III PACT Study of TNFerade at ASCO 4
...igation system for ENT, cranial and spine procedur...y, critical zones visible during tracking. Image f...n freezes image, snapshot can be taken of frozen i...the microscope, low profile receiver attachment. A...
The spinal system neon is a modular system for posterior stabilization. Its application range extends from occipitocervical via cervical to cervicothoracic applications. In the case of children, it c
Bacon Cranial Rongeur
Cushing Pituitary Rongeur
Medicine Products: